Search
Patexia Research
Case number 1:21-cv-00022

Pfizer Inc. et al v. Aurobindo Pharma Ltd. et al > Documents

Date Field Doc. No.Description (Pages)
May 6, 2022 44 Stipulation of Dismissal (2)
May 6, 2022 44 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E; 6,965,027 B2. (Attachments: # (1) Stipulation of Dismissal)(kmd)
May 6, 2022 43 SO ORDERED (2)
Docket Text: SO ORDERED, re [42] Stipulation of Dismissal, filed by PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V. CASE CLOSED. Signed by Judge Colm F. Connolly on 5/6/2022. (kmd)
May 5, 2022 42 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
May 3, 2022 41 SO ORDERED (2)
Docket Text: SO ORDERED, re [40] STIPULATION TO EXTEND TIME of certain case deadlines to various dates, filed by PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V. Re-Setting Scheduling Order Deadlines: Fact Discovery completed by 5/16/2022. Opening Expert Reports due by 6/15/2022. Rebuttal Expert Reports due by 7/27/2022. Reply Expert Reports due by 8/24/2022. Reply Expert Reports regarding Secondary Considerations of Non-Obviousness due by 9/14/2022. Signed by Judge Colm F. Connolly on 5/3/2022. (kmd)
May 2, 2022 40 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME of certain case deadlines to various dates - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Apr 20, 2022 N/A Case No Longer Referred to Mediation (0)
Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb)
Apr 14, 2022 39 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Apr 8, 2022 38 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1- 2) and Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-3) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Apr 1, 2022 37 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55) and Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s First Set of Interrogatories to Plaintiffs (Nos. 1-11) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Mar 29, 2022 36 Notice to Take Deposition (4)
Docket Text: NOTICE to Take Deposition of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on April 25, 2022 filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Mar 11, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-00022-CFC, 1:21-cv-01427-CFC, 1:22-cv-00191-CFC, 1:22-cv-00192-CFC (rjb)
Mar 9, 2022 35 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Pfizer's First Set of Interrogatories to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.; and (2) Pfizer's First Set of Requests to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. for the Production of Documents and Things filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Jan 21, 2022 34 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions, Pursuant to Paragraph 4(d) of the District of Delaware's Default Standard for Discovery filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Jan 13, 2022 33 Notice Requesting Removal of Co-Counsel (2)
Docket Text: NOTICE requesting Clerk to remove Stephanie Piper as co-counsel. Reason for request: No longer with firm. (Dellinger, Megan)
Jan 12, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [32] Stipulation and Order for Extension of Time filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 1/12/22. (ntl)
Jan 10, 2022 32 Stipulation (2)
Docket Text: STIPULATION and Proposed Order for Extension of Time for Defendants to Serve Initial Invalidity Contentions by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.)
Jan 6, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [31] Joint Stipulated Claim construction Order. All dates pertaining to claim construction, including the June 27, 2022 Markman Hearing, are cancelled as moot. Signed by Judge Leonard P. Stark on 1/6/22. (ntl)
Jan 5, 2022 31 Proposed Order (3)
Docket Text: Joint PROPOSED ORDER -- Claim Construction -- by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Dec 20, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 6, 2021 30 Notice (Other) (1)
Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth)
Dec 1, 2021 29 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Pfizer's Infringement Claim Charts Regarding the Accused Product of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Nov 29, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Timothy H. Kratz for Aurobindo Pharma Ltd.,and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Nov 18, 2021 28 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.)
Oct 29, 2021 27 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Aurobindo's Core Technical Documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
Oct 26, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [26] STIPULATED PROTECTIVE ORDER. Signed by Judge Leonard P. Stark on 10/26/21. (ntl)
Oct 22, 2021 26 Proposed Order (30)
Docket Text: PROPOSED ORDER -- Protective Order -- by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Oct 19, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 10/19/21. (ntl)
Oct 18, 2021 25 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
Oct 15, 2021 23 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Pfizer's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Oct 15, 2021 24 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
Oct 7, 2021 22 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Pfizer's Identification of Accused Products and Asserted Patents filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Sep 24, 2021 20 Scheduling Order (14)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 5/2/2022. Status Report due by 5/13/2022. Joint Claim Construction Brief due by 4/29/2022. A Markman Hearing is set for 6/27/2022 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 2/21/2023. A Final Pretrial Conference is set for 3/3/2023 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 3/13/2023 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/24/21. (ntl)
Sep 24, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 9/24/2021. (dlb)
Sep 24, 2021 18 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
Sep 24, 2021 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel)
Sep 24, 2021 19 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Pfizer's Fed. R. Civ. P. 26(a) Initial Disclosure Statement filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc..(Dellinger, Megan)
Sep 23, 2021 17 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Soumitra Deka - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Sep 23, 2021 16 Motion for Leave to Appear Pro Hac Vice (7)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Stephanie Piper and Michael Sapiro - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Sep 23, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Soumitra Deka filed by PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V., [16] MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Stephanie Piper and Michael Sapiro filed by PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V. Signed by Judge Leonard P. Stark on 9/23/21. (ntl)
Sep 20, 2021 15 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Timothy H. Kratz - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
Sep 20, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Timothy H. Kratz filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 9/20/21. (ntl)
Sep 13, 2021 14 Letter to The Honorable Leonard P. Stark (1)
Sep 13, 2021 14 Main Document (14)
Docket Text: PROPOSED ORDER -- Scheduling Order -- by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Dellinger, Megan)
Sep 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [13] STIPULATION TO EXTEND TIME Submit Proposed Scheduling Order to September 13, 2021 filed by Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 9/9/21. (ntl)
Sep 8, 2021 13 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME Submit Proposed Scheduling Order to September 13, 2021 - filed by Aurobindo Pharma Ltd.. (Hitch, Cortlan)
Sep 1, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME for the parties to file the Proposed Scheduling Order to September 9, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 9/1/21. (ntl)
Aug 31, 2021 12 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file the Proposed Scheduling Order to September 9, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
Aug 19, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 2, 2021. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/19/21. (ntl)
Feb 2, 2021 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
Feb 2, 2021 9 Answer to Complaint (18)
Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
Jan 13, 2021 8 Affidavit of Service (10)
Docket Text: AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Ltd. on January 12, 2021, filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Jan 13, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Jan 12, 2021 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. Aurobindo Pharma USA, Inc. served on 1/12/2021, answer due 2/2/2021. (Dellinger, Megan)
Jan 12, 2021 6 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (amf)
Jan 11, 2021 1 Main Document (14)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 402, receipt number ADEDC-3455406) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(amf)
Jan 11, 2021 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., and PF PRISM IMB B.V. - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., and Pfizer Inc. (amf)
Jan 11, 2021 4 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/30/2020. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 5/30/2023. (amf)
Jan 11, 2021 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E ;6,965,027 B2. (amf)
Jan 11, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf)
Jan 11, 2021 1 Civil Cover Sheet (2)
Jan 11, 2021 1 Exhibit A-B (26)
Jan 11, 2021 1 Complaint* (1)
Menu